Showing results (11-20 of 87) with videos related to
Sort By:
Pageof 9
Trends in Neurosciences|August 1, 2019
Anxiety and Brain Mitochondria: A Bidirectional CrosstalkMichaela D Filiou, Carmen SandiMethods in Molecular Biology (Clifton, N.J.)|January 11, 2012
Psychiatric disorder biomarker discovery using quantitative proteomicsMichaela D Filiou, Christoph W TurckInternational Review of Neurobiology|November 5, 2011
General overview: biomarkers in neuroscience researchMichaela D Filiou, Christoph W TurckPlos One|November 17, 2009
Stable isotope metabolic labeling with a novel N-enriched bacteria diet for improved proteomic analyses of mouse models for psychopathologiesElisabeth Frank, Melanie S Kessler, Michaela D Filiou, et al.Molecular & Cellular Proteomics : MCP|August 25, 2011
Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathwaysYaoyang Zhang, Michaela D Filiou, Stefan Reckow, et al.Neuroscience and Biobehavioral Reviews|August 1, 2024
Mitochondrial dynamics and psychiatric disorders: The missing linkMaria P Papageorgiou, Michaela D FiliouMolecular Neuropsychiatry|September 8, 2016
What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders?Christoph W Turck, Michaela D FiliouProteomics|June 16, 2012
The (15)N isotope effect as a means for correlating phenotypic alterations and affected pathways in a trait anxiety mouse modelMichaela D Filiou, Christian Webhofer, Philipp Gormanns, et al.Molecular Neuropsychiatry|April 26, 2019
Ketamine's Effects on the Glutamatergic and GABAergic Systems: A Proteomics and Metabolomics Study in MiceKatja Weckmann, Michael J Deery, Julie A Howard, et al.CNS & Neurological Disorders Drug Targets|October 7, 2017
The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation FogMichaela D Filiou, Richard B Banati, Manuel B GraeberPageof 9